Navigation Links
Vermillion Announces Presentation of Positive Ovarian Biomarker Data for Next Generation Test
Date:3/8/2011

AUSTIN, Texas, March 8, 2011 /PRNewswire/ -- (Nasdaq: VRML) –Vermillion, a molecular diagnostics company, today announced the presentation of positive preliminary data from its collaboration with Johns Hopkins University School of Medicine to identify biomarkers that improve on the specificity of CA125 for the identification of malignant ovarian tumors.  These results were presented at the 42nd Annual Meeting on Women's Cancer of the Society of Gynecologic Oncologists, March 6-9, 2011 in Orlando, Florida.

The poster titled "Identification of Biomarkers to Improve Specificity in Preoperative Assessment of Ovarian Tumor for Risk of Cancer" evaluated more than 20 candidate biomarkers for their ability to complement CA125 in distinguishing benign from malignant ovarian tumors, with an emphasis on markers that could improve on the clinical specificity. Of the candidate markers, three markers demonstrated the ability to complement CA125 using multivariate logistic regression. These studies were conducted by Drs. Daniel Chan and Zhen Zhang at the Johns Hopkins University School of Medicine.  Dr. Chan is Professor of Pathology, Oncology, Radiology, and Urology at the Johns Hopkins University School of Medicine, and Director of the Clinical Chemistry Division and Co-Director of the Pathology Core Laboratory of Johns Hopkins Hospital. He is also Director of the Biomarker Discovery Center at Johns Hopkins University. Dr. Zhen Zhang is an Associate Professor of Pathology also at the Johns Hopkins University School of Medicine.

"Markers that can improve the clinical specificity of current tools for ovarian cancer detection will enhance our ability to test patients in whom cancer is suspected. These results pave the way for further studies that could lead to additional novel tests in the ovarian cancer space," said Dr. Eric T. Fung, Chief Science Officer at Vermilli
'/>"/>

SOURCE Vermillion, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Vermillion Attends 42nd Annual Meeting of the Society of Gynecologic Oncologists
2. Vermillion to Present at the Roth 23rd Annual OC Growth Stock Conference March 13-16, 2011, Laguna Niguel, CA
3. Vermillion Announces $21.8 Million Public Offering
4. Vermillion to Host Conference Call and Web Cast to Present Company Update and Review Financial Results for the Fourth Quarter 2010
5. Vermillion Announces Issuance of Patent for Peripheral Artery Disease
6. Vermillion Reappoints Three Directors, Approves a New Stock Incentive Plan, and Ratifies PricewaterhouseCoopers LLP as Its Accounting Firm
7. Vermillion Reports Financial Results for the Third Quarter 2010
8. Vermillion to Host Conference Call and Web Cast to Present Company Update and Review Financial Results for the Second Quarter 2010
9. Vermillion Announces Relocation of Corporate Offices to Austin, Texas
10. Vermillion Announces Issuance of Patent for Alzheimers Disease Diagnosis
11. Vermillion to Present at the Roth 22nd Annual OC Growth Stock Conference March 15 - 17, Laguna Niguel, CA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... MELBOURNE, Australia , Sept. 18, 2014 ... appointments of Dr. Ashraf Hanna , M.D., Ph.D., ... its Board of Directors. Dr. Hanna is the Vice ... and Chief Financial Officer for the Genentech Foundation, while ... Global Head of Business Development and Licensing for Roche ...
(Date:9/18/2014)... , Sept. 18, 2014 Relmada Therapeutics, ... for the treatment of chronic pain, announced today that ... to the position of  Senior Director of Clinical Development. ... Mr. James has established and led successful global clinical ... , to facilitate the clinical development of numerous ...
(Date:9/18/2014)... Sept. 18, 2014 /CNW/ - A new expert panel report, ... , released today by the Council of ... effective medicines for children. Each year about half of ... at least one prescription drug. Much of this prescribing ... authorized use), creating potential health risks. Children ...
Breaking Medicine Technology:Nexvet Appoints Ashraf Hanna and Joseph McCracken to Board of Directors 2Nexvet Appoints Ashraf Hanna and Joseph McCracken to Board of Directors 3Relmada Therapeutics, Inc. Appoints Christopher W. James As Senior Director of Clinical Development 2Studying medicines in children is always possible and is in their best interest, finds Expert Panel 2Studying medicines in children is always possible and is in their best interest, finds Expert Panel 3
(Date:9/18/2014)... 18, 2014 Alexandria, VA — The ... that 10 more communities have joined the growing ranks ... department accreditation. The decisions bring the number of governmental ... PHAB is the non-profit organization that administers the national ... protect the health of the public by advancing the ...
(Date:9/18/2014)... THURSDAY, Sept. 18, 2014 (HealthDay News) -- Older people ... That,s because the balance of stress hormones during ... result, older people who are grieving are more likely ... study found. "During the difficult weeks and months ... Neutrophils are the most abundant type of white blood ...
(Date:9/18/2014)... San Luis Obispo, CA (PRWEB) September 18, 2014 ... Bunion Bootie introduced their newest, patent pending bunion splint ... , As one loyalist, Rosa, wrote: "I was absolutely delighted. ... comfortable... I honestly forget I am wearing them. THANK YOU ... the recently introduced design by saying, "The hole used to ...
(Date:9/18/2014)... Alan Mozes HealthDay Reporter ... it comes to emergency room waiting times, patients seeking care ... staring down the clock than those seen at smaller or ... crowding and our ability to provide timely emergency care varies ... the authors of the new research, Dr. Renee Hsia, an ...
(Date:9/18/2014)... Physicians (CHEST) together with the Chinese Thoracic Society ... CTS that CHEST World Congress 2016 will be ... care, and sleep medicine from around the world ... for spring 2016. , CHEST World Congress ... simulation training, keynote addresses, presentations by leading health-care ...
Breaking Medicine News(10 mins):Health News:Ten More Communities Reaping Benefits of National Accreditation 2Health News:Ten More Communities Reaping Benefits of National Accreditation 3Health News:Ten More Communities Reaping Benefits of National Accreditation 4Health News:Grief Can Weigh on Immune System in Older Folks, Study Says 2Health News:Feedback for the New Bunion Bootie Design Feedback is Already Pouring In, and Bunion Sufferers Love It 2Health News:Feedback for the New Bunion Bootie Design Feedback is Already Pouring In, and Bunion Sufferers Love It 3Health News:ER Waiting Times Vary Significantly, Studies Find 2Health News:ER Waiting Times Vary Significantly, Studies Find 3Health News:CHEST announces China as site of CHEST World Congress 2016 2
... Research from the University of Sheffield has found that people are ... per year, for greener urban spaces. Researchers surveyed the public ... find out how much extra they were willing to pay in ... area. They found that people were willing to pay more for ...
... group of researchers at the University of California, San Francisco ... and red serpent called the Texas coral snake can be ... and acute pain and provides new research tools that ... The venom contains a toxic mixture of chemicals that includes ...
... , THURSDAY, Nov. 17 (HealthDay News) -- Young athletes who ... -- even if they do not suffer a concussion, according ... from the University of Rochester Medical Center (URMC) said their ... consequences of seemingly mild head injuries among young people whose ...
... -- An international team of researchers led by clinicians at ... in an aggressive type of prostate cancer -- a vulnerability ... is already in clinical trials to treat other types of ... the researchers report that the investigational drug had a dramatic ...
... Gordon HealthDay Reporter , WEDNESDAY, Nov. 16 ... mofetil (CellCept) is better at controlling a serious kidney ... new study suggests. People taking mycophenolate were about ... were people taking azathioprine (Imuran), according to the researchers. ...
... Gardner HealthDay Reporter , WEDNESDAY, Nov. 16 (HealthDay ... healthy have a good chance of staving off cancer as ... maintain a healthy body-mass index (BMI), normal blood pressure and ... a 38 percent lower risk of developing cancer, according to ...
Cached Medicine News:Health News:Public willing to pay more for greener urban spaces 2Health News:Public willing to pay more for greener urban spaces 3Health News:Snake spills venomous secrets 2Health News:Snake spills venomous secrets 3Health News:Routine Head Hits in Sports May Injure Brain, Experts Warn 2Health News:Researchers discover Achilles' heel in lethal form of prostate cancer 2Health News:Researchers discover Achilles' heel in lethal form of prostate cancer 3Health News:Researchers discover Achilles' heel in lethal form of prostate cancer 4Health News:Newer Drug Seems Better at Controlling Lupus Kidney Complication 2Health News:Newer Drug Seems Better at Controlling Lupus Kidney Complication 3Health News:Healthy Heart Habits May Also Guard Against Cancer 2Health News:Healthy Heart Habits May Also Guard Against Cancer 3
... Arthrotek® Precision Hand Instruments were developed ... tactile feel, while still having an instrument ... spaces without the fear of the bending ... designed and manufactured to conform to the ...
... Instruments were developed in surgeon's desire to ... having an instrument with the strength to ... of the bending or breaking. Arthrotek Hand ... conform to the surgeon's hand. This new ...
... developed in surgeon's desire to have the ... instrument with the strength to maneuver into ... bending or breaking. Arthrotek Hand Instruments are ... the surgeon's hand. This new generation of ...
... Precision Hand Instruments were developed in surgeon's ... while still having an instrument with the ... the fear of the bending or breaking. ... manufactured to conform to the surgeon's hand. ...
Medicine Products: